nodes	percent_of_prediction	percent_of_DWPC	metapath
Rotigotine—CYP3A4—prostate cancer	0.168	1	CbGaD
Rotigotine—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0528	0.113	CbGbCtD
Rotigotine—CYP1A2—Flutamide—prostate cancer	0.0438	0.0937	CbGbCtD
Rotigotine—CYP2D6—Bicalutamide—prostate cancer	0.0436	0.0931	CbGbCtD
Rotigotine—CYP2D6—Abiraterone—prostate cancer	0.0361	0.0772	CbGbCtD
Rotigotine—CYP1A2—Estrone—prostate cancer	0.0317	0.0677	CbGbCtD
Rotigotine—CYP3A4—Bicalutamide—prostate cancer	0.0277	0.0592	CbGbCtD
Rotigotine—CYP3A4—Estramustine—prostate cancer	0.0258	0.0551	CbGbCtD
Rotigotine—CYP3A4—Abiraterone—prostate cancer	0.023	0.0491	CbGbCtD
Rotigotine—CYP3A4—Flutamide—prostate cancer	0.023	0.0491	CbGbCtD
Rotigotine—CYP1A2—Conjugated Estrogens—prostate cancer	0.0207	0.0443	CbGbCtD
Rotigotine—CYP1A2—Estradiol—prostate cancer	0.0182	0.0389	CbGbCtD
Rotigotine—CYP3A4—Cabazitaxel—prostate cancer	0.017	0.0363	CbGbCtD
Rotigotine—CYP3A4—Estrone—prostate cancer	0.0166	0.0355	CbGbCtD
Rotigotine—CYP3A4—Ethinyl Estradiol—prostate cancer	0.0148	0.0316	CbGbCtD
Rotigotine—CYP1A2—Etoposide—prostate cancer	0.0119	0.0254	CbGbCtD
Rotigotine—CYP3A4—Conjugated Estrogens—prostate cancer	0.0109	0.0232	CbGbCtD
Rotigotine—CYP3A4—Mitoxantrone—prostate cancer	0.00988	0.0211	CbGbCtD
Rotigotine—CYP3A4—Estradiol—prostate cancer	0.00954	0.0204	CbGbCtD
Rotigotine—CYP3A4—Prednisone—prostate cancer	0.0082	0.0175	CbGbCtD
Rotigotine—CYP2D6—Doxorubicin—prostate cancer	0.00668	0.0143	CbGbCtD
Rotigotine—CYP3A4—Etoposide—prostate cancer	0.00623	0.0133	CbGbCtD
Rotigotine—CYP3A4—Docetaxel—prostate cancer	0.0057	0.0122	CbGbCtD
Rotigotine—CYP3A4—Doxorubicin—prostate cancer	0.00425	0.00908	CbGbCtD
Rotigotine—Infestation NOS—Epirubicin—prostate cancer	0.000102	0.000426	CcSEcCtD
Rotigotine—Infestation—Epirubicin—prostate cancer	0.000102	0.000426	CcSEcCtD
Rotigotine—Erythema—Prednisone—prostate cancer	0.000102	0.000426	CcSEcCtD
Rotigotine—Malnutrition—Prednisone—prostate cancer	0.000102	0.000426	CcSEcCtD
Rotigotine—Decreased appetite—Etoposide—prostate cancer	0.000101	0.000421	CcSEcCtD
Rotigotine—Arthralgia—Docetaxel—prostate cancer	0.000101	0.00042	CcSEcCtD
Rotigotine—Loss of consciousness—Capecitabine—prostate cancer	0.000101	0.00042	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Etoposide—prostate cancer	0.0001	0.000418	CcSEcCtD
Rotigotine—Asthenia—Mitoxantrone—prostate cancer	0.0001	0.000418	CcSEcCtD
Rotigotine—Fatigue—Etoposide—prostate cancer	0.0001	0.000418	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	0.0001	0.000417	CcSEcCtD
Rotigotine—Cough—Capecitabine—prostate cancer	9.99e-05	0.000417	CcSEcCtD
Rotigotine—Pain—Etoposide—prostate cancer	9.93e-05	0.000414	CcSEcCtD
Rotigotine—Constipation—Etoposide—prostate cancer	9.93e-05	0.000414	CcSEcCtD
Rotigotine—Dizziness—Estradiol—prostate cancer	9.91e-05	0.000413	CcSEcCtD
Rotigotine—Hypertension—Capecitabine—prostate cancer	9.89e-05	0.000412	CcSEcCtD
Rotigotine—Dry mouth—Docetaxel—prostate cancer	9.85e-05	0.000411	CcSEcCtD
Rotigotine—Upper respiratory tract infection—Doxorubicin—prostate cancer	9.85e-05	0.000411	CcSEcCtD
Rotigotine—Arthralgia—Capecitabine—prostate cancer	9.75e-05	0.000407	CcSEcCtD
Rotigotine—Confusional state—Docetaxel—prostate cancer	9.73e-05	0.000406	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	9.68e-05	0.000404	CcSEcCtD
Rotigotine—Weight increased—Doxorubicin—prostate cancer	9.64e-05	0.000402	CcSEcCtD
Rotigotine—Discomfort—Capecitabine—prostate cancer	9.63e-05	0.000402	CcSEcCtD
Rotigotine—Infection—Docetaxel—prostate cancer	9.59e-05	0.0004	CcSEcCtD
Rotigotine—Weight decreased—Doxorubicin—prostate cancer	9.59e-05	0.0004	CcSEcCtD
Rotigotine—Sinusitis—Epirubicin—prostate cancer	9.58e-05	0.0004	CcSEcCtD
Rotigotine—Feeling abnormal—Etoposide—prostate cancer	9.57e-05	0.000399	CcSEcCtD
Rotigotine—Diarrhoea—Mitoxantrone—prostate cancer	9.56e-05	0.000399	CcSEcCtD
Rotigotine—Dry mouth—Capecitabine—prostate cancer	9.54e-05	0.000398	CcSEcCtD
Rotigotine—Vomiting—Estradiol—prostate cancer	9.53e-05	0.000398	CcSEcCtD
Rotigotine—Shock—Docetaxel—prostate cancer	9.5e-05	0.000396	CcSEcCtD
Rotigotine—Nervous system disorder—Docetaxel—prostate cancer	9.47e-05	0.000395	CcSEcCtD
Rotigotine—Ill-defined disorder—Prednisone—prostate cancer	9.47e-05	0.000395	CcSEcCtD
Rotigotine—Rash—Estradiol—prostate cancer	9.45e-05	0.000394	CcSEcCtD
Rotigotine—Infestation NOS—Doxorubicin—prostate cancer	9.45e-05	0.000394	CcSEcCtD
Rotigotine—Infestation—Doxorubicin—prostate cancer	9.45e-05	0.000394	CcSEcCtD
Rotigotine—Dermatitis—Estradiol—prostate cancer	9.44e-05	0.000394	CcSEcCtD
Rotigotine—Confusional state—Capecitabine—prostate cancer	9.42e-05	0.000393	CcSEcCtD
Rotigotine—Headache—Estradiol—prostate cancer	9.39e-05	0.000392	CcSEcCtD
Rotigotine—Skin disorder—Docetaxel—prostate cancer	9.38e-05	0.000391	CcSEcCtD
Rotigotine—Agitation—Prednisone—prostate cancer	9.37e-05	0.000391	CcSEcCtD
Rotigotine—Angioedema—Prednisone—prostate cancer	9.32e-05	0.000389	CcSEcCtD
Rotigotine—Infection—Capecitabine—prostate cancer	9.29e-05	0.000387	CcSEcCtD
Rotigotine—Urticaria—Etoposide—prostate cancer	9.23e-05	0.000385	CcSEcCtD
Rotigotine—Anorexia—Docetaxel—prostate cancer	9.2e-05	0.000384	CcSEcCtD
Rotigotine—Malaise—Prednisone—prostate cancer	9.2e-05	0.000384	CcSEcCtD
Rotigotine—Shock—Capecitabine—prostate cancer	9.2e-05	0.000384	CcSEcCtD
Rotigotine—Nervous system disorder—Capecitabine—prostate cancer	9.17e-05	0.000382	CcSEcCtD
Rotigotine—Vertigo—Prednisone—prostate cancer	9.17e-05	0.000382	CcSEcCtD
Rotigotine—Syncope—Prednisone—prostate cancer	9.15e-05	0.000382	CcSEcCtD
Rotigotine—Skin disorder—Capecitabine—prostate cancer	9.08e-05	0.000379	CcSEcCtD
Rotigotine—Hyperhidrosis—Capecitabine—prostate cancer	9.04e-05	0.000377	CcSEcCtD
Rotigotine—Oedema peripheral—Epirubicin—prostate cancer	9.03e-05	0.000377	CcSEcCtD
Rotigotine—Hypotension—Docetaxel—prostate cancer	9.02e-05	0.000376	CcSEcCtD
Rotigotine—Connective tissue disorder—Epirubicin—prostate cancer	9.01e-05	0.000376	CcSEcCtD
Rotigotine—Loss of consciousness—Prednisone—prostate cancer	8.97e-05	0.000374	CcSEcCtD
Rotigotine—Anorexia—Capecitabine—prostate cancer	8.91e-05	0.000372	CcSEcCtD
Rotigotine—Nausea—Estradiol—prostate cancer	8.9e-05	0.000371	CcSEcCtD
Rotigotine—Vomiting—Mitoxantrone—prostate cancer	8.88e-05	0.00037	CcSEcCtD
Rotigotine—Sinusitis—Doxorubicin—prostate cancer	8.86e-05	0.00037	CcSEcCtD
Rotigotine—Visual impairment—Epirubicin—prostate cancer	8.83e-05	0.000368	CcSEcCtD
Rotigotine—Hypertension—Prednisone—prostate cancer	8.81e-05	0.000367	CcSEcCtD
Rotigotine—Rash—Mitoxantrone—prostate cancer	8.81e-05	0.000367	CcSEcCtD
Rotigotine—Dermatitis—Mitoxantrone—prostate cancer	8.8e-05	0.000367	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Docetaxel—prostate cancer	8.8e-05	0.000367	CcSEcCtD
Rotigotine—Headache—Mitoxantrone—prostate cancer	8.75e-05	0.000365	CcSEcCtD
Rotigotine—Hypotension—Capecitabine—prostate cancer	8.73e-05	0.000364	CcSEcCtD
Rotigotine—Insomnia—Docetaxel—prostate cancer	8.73e-05	0.000364	CcSEcCtD
Rotigotine—Arthralgia—Prednisone—prostate cancer	8.69e-05	0.000362	CcSEcCtD
Rotigotine—Paraesthesia—Docetaxel—prostate cancer	8.67e-05	0.000362	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	8.63e-05	0.00036	CcSEcCtD
Rotigotine—Somnolence—Docetaxel—prostate cancer	8.58e-05	0.000358	CcSEcCtD
Rotigotine—Discomfort—Prednisone—prostate cancer	8.58e-05	0.000358	CcSEcCtD
Rotigotine—Hypersensitivity—Etoposide—prostate cancer	8.56e-05	0.000357	CcSEcCtD
Rotigotine—Tinnitus—Epirubicin—prostate cancer	8.55e-05	0.000356	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Capecitabine—prostate cancer	8.52e-05	0.000355	CcSEcCtD
Rotigotine—Dyspepsia—Docetaxel—prostate cancer	8.5e-05	0.000355	CcSEcCtD
Rotigotine—Insomnia—Capecitabine—prostate cancer	8.45e-05	0.000353	CcSEcCtD
Rotigotine—Paraesthesia—Capecitabine—prostate cancer	8.39e-05	0.00035	CcSEcCtD
Rotigotine—Decreased appetite—Docetaxel—prostate cancer	8.39e-05	0.00035	CcSEcCtD
Rotigotine—Oedema peripheral—Doxorubicin—prostate cancer	8.35e-05	0.000349	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Docetaxel—prostate cancer	8.33e-05	0.000348	CcSEcCtD
Rotigotine—Asthenia—Etoposide—prostate cancer	8.33e-05	0.000348	CcSEcCtD
Rotigotine—Connective tissue disorder—Doxorubicin—prostate cancer	8.33e-05	0.000348	CcSEcCtD
Rotigotine—Fatigue—Docetaxel—prostate cancer	8.32e-05	0.000347	CcSEcCtD
Rotigotine—Angiopathy—Epirubicin—prostate cancer	8.32e-05	0.000347	CcSEcCtD
Rotigotine—Nausea—Mitoxantrone—prostate cancer	8.3e-05	0.000346	CcSEcCtD
Rotigotine—Immune system disorder—Epirubicin—prostate cancer	8.28e-05	0.000345	CcSEcCtD
Rotigotine—Infection—Prednisone—prostate cancer	8.27e-05	0.000345	CcSEcCtD
Rotigotine—Mediastinal disorder—Epirubicin—prostate cancer	8.26e-05	0.000345	CcSEcCtD
Rotigotine—Constipation—Docetaxel—prostate cancer	8.26e-05	0.000344	CcSEcCtD
Rotigotine—Pain—Docetaxel—prostate cancer	8.26e-05	0.000344	CcSEcCtD
Rotigotine—Dyspepsia—Capecitabine—prostate cancer	8.23e-05	0.000343	CcSEcCtD
Rotigotine—Pruritus—Etoposide—prostate cancer	8.22e-05	0.000343	CcSEcCtD
Rotigotine—Shock—Prednisone—prostate cancer	8.19e-05	0.000342	CcSEcCtD
Rotigotine—Visual impairment—Doxorubicin—prostate cancer	8.17e-05	0.000341	CcSEcCtD
Rotigotine—Nervous system disorder—Prednisone—prostate cancer	8.16e-05	0.000341	CcSEcCtD
Rotigotine—Decreased appetite—Capecitabine—prostate cancer	8.13e-05	0.000339	CcSEcCtD
Rotigotine—Skin disorder—Prednisone—prostate cancer	8.09e-05	0.000337	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Capecitabine—prostate cancer	8.07e-05	0.000337	CcSEcCtD
Rotigotine—Fatigue—Capecitabine—prostate cancer	8.06e-05	0.000336	CcSEcCtD
Rotigotine—Hyperhidrosis—Prednisone—prostate cancer	8.05e-05	0.000336	CcSEcCtD
Rotigotine—Mental disorder—Epirubicin—prostate cancer	8.03e-05	0.000335	CcSEcCtD
Rotigotine—Pain—Capecitabine—prostate cancer	7.99e-05	0.000333	CcSEcCtD
Rotigotine—Constipation—Capecitabine—prostate cancer	7.99e-05	0.000333	CcSEcCtD
Rotigotine—Malnutrition—Epirubicin—prostate cancer	7.98e-05	0.000333	CcSEcCtD
Rotigotine—Erythema—Epirubicin—prostate cancer	7.98e-05	0.000333	CcSEcCtD
Rotigotine—Feeling abnormal—Docetaxel—prostate cancer	7.96e-05	0.000332	CcSEcCtD
Rotigotine—Diarrhoea—Etoposide—prostate cancer	7.95e-05	0.000332	CcSEcCtD
Rotigotine—Anorexia—Prednisone—prostate cancer	7.94e-05	0.000331	CcSEcCtD
Rotigotine—Tinnitus—Doxorubicin—prostate cancer	7.91e-05	0.00033	CcSEcCtD
Rotigotine—Feeling abnormal—Capecitabine—prostate cancer	7.7e-05	0.000321	CcSEcCtD
Rotigotine—Angiopathy—Doxorubicin—prostate cancer	7.69e-05	0.000321	CcSEcCtD
Rotigotine—Dizziness—Etoposide—prostate cancer	7.68e-05	0.00032	CcSEcCtD
Rotigotine—Muscle spasms—Epirubicin—prostate cancer	7.67e-05	0.00032	CcSEcCtD
Rotigotine—Immune system disorder—Doxorubicin—prostate cancer	7.66e-05	0.00032	CcSEcCtD
Rotigotine—Mediastinal disorder—Doxorubicin—prostate cancer	7.64e-05	0.000319	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Prednisone—prostate cancer	7.59e-05	0.000316	CcSEcCtD
Rotigotine—Insomnia—Prednisone—prostate cancer	7.53e-05	0.000314	CcSEcCtD
Rotigotine—Paraesthesia—Prednisone—prostate cancer	7.48e-05	0.000312	CcSEcCtD
Rotigotine—Mental disorder—Doxorubicin—prostate cancer	7.43e-05	0.00031	CcSEcCtD
Rotigotine—Urticaria—Capecitabine—prostate cancer	7.43e-05	0.00031	CcSEcCtD
Rotigotine—Ill-defined disorder—Epirubicin—prostate cancer	7.4e-05	0.000309	CcSEcCtD
Rotigotine—Vomiting—Etoposide—prostate cancer	7.39e-05	0.000308	CcSEcCtD
Rotigotine—Erythema—Doxorubicin—prostate cancer	7.38e-05	0.000308	CcSEcCtD
Rotigotine—Malnutrition—Doxorubicin—prostate cancer	7.38e-05	0.000308	CcSEcCtD
Rotigotine—Agitation—Epirubicin—prostate cancer	7.33e-05	0.000306	CcSEcCtD
Rotigotine—Dyspepsia—Prednisone—prostate cancer	7.33e-05	0.000306	CcSEcCtD
Rotigotine—Rash—Etoposide—prostate cancer	7.32e-05	0.000306	CcSEcCtD
Rotigotine—Dermatitis—Etoposide—prostate cancer	7.32e-05	0.000305	CcSEcCtD
Rotigotine—Headache—Etoposide—prostate cancer	7.28e-05	0.000304	CcSEcCtD
Rotigotine—Decreased appetite—Prednisone—prostate cancer	7.24e-05	0.000302	CcSEcCtD
Rotigotine—Malaise—Epirubicin—prostate cancer	7.19e-05	0.0003	CcSEcCtD
Rotigotine—Fatigue—Prednisone—prostate cancer	7.18e-05	0.000299	CcSEcCtD
Rotigotine—Vertigo—Epirubicin—prostate cancer	7.17e-05	0.000299	CcSEcCtD
Rotigotine—Syncope—Epirubicin—prostate cancer	7.15e-05	0.000298	CcSEcCtD
Rotigotine—Constipation—Prednisone—prostate cancer	7.12e-05	0.000297	CcSEcCtD
Rotigotine—Hypersensitivity—Docetaxel—prostate cancer	7.11e-05	0.000297	CcSEcCtD
Rotigotine—Muscle spasms—Doxorubicin—prostate cancer	7.1e-05	0.000296	CcSEcCtD
Rotigotine—Loss of consciousness—Epirubicin—prostate cancer	7.01e-05	0.000293	CcSEcCtD
Rotigotine—Cough—Epirubicin—prostate cancer	6.96e-05	0.00029	CcSEcCtD
Rotigotine—Asthenia—Docetaxel—prostate cancer	6.93e-05	0.000289	CcSEcCtD
Rotigotine—Nausea—Etoposide—prostate cancer	6.9e-05	0.000288	CcSEcCtD
Rotigotine—Hypertension—Epirubicin—prostate cancer	6.89e-05	0.000287	CcSEcCtD
Rotigotine—Hypersensitivity—Capecitabine—prostate cancer	6.89e-05	0.000287	CcSEcCtD
Rotigotine—Feeling abnormal—Prednisone—prostate cancer	6.86e-05	0.000286	CcSEcCtD
Rotigotine—Ill-defined disorder—Doxorubicin—prostate cancer	6.85e-05	0.000286	CcSEcCtD
Rotigotine—Pruritus—Docetaxel—prostate cancer	6.83e-05	0.000285	CcSEcCtD
Rotigotine—Arthralgia—Epirubicin—prostate cancer	6.79e-05	0.000283	CcSEcCtD
Rotigotine—Agitation—Doxorubicin—prostate cancer	6.78e-05	0.000283	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	6.75e-05	0.000281	CcSEcCtD
Rotigotine—Discomfort—Epirubicin—prostate cancer	6.71e-05	0.00028	CcSEcCtD
Rotigotine—Asthenia—Capecitabine—prostate cancer	6.71e-05	0.00028	CcSEcCtD
Rotigotine—Malaise—Doxorubicin—prostate cancer	6.66e-05	0.000278	CcSEcCtD
Rotigotine—Dry mouth—Epirubicin—prostate cancer	6.64e-05	0.000277	CcSEcCtD
Rotigotine—Vertigo—Doxorubicin—prostate cancer	6.63e-05	0.000277	CcSEcCtD
Rotigotine—Syncope—Doxorubicin—prostate cancer	6.62e-05	0.000276	CcSEcCtD
Rotigotine—Urticaria—Prednisone—prostate cancer	6.61e-05	0.000276	CcSEcCtD
Rotigotine—Pruritus—Capecitabine—prostate cancer	6.61e-05	0.000276	CcSEcCtD
Rotigotine—Diarrhoea—Docetaxel—prostate cancer	6.61e-05	0.000276	CcSEcCtD
Rotigotine—Confusional state—Epirubicin—prostate cancer	6.57e-05	0.000274	CcSEcCtD
Rotigotine—Loss of consciousness—Doxorubicin—prostate cancer	6.49e-05	0.000271	CcSEcCtD
Rotigotine—Infection—Epirubicin—prostate cancer	6.47e-05	0.00027	CcSEcCtD
Rotigotine—Cough—Doxorubicin—prostate cancer	6.44e-05	0.000269	CcSEcCtD
Rotigotine—Shock—Epirubicin—prostate cancer	6.41e-05	0.000267	CcSEcCtD
Rotigotine—Diarrhoea—Capecitabine—prostate cancer	6.4e-05	0.000267	CcSEcCtD
Rotigotine—Nervous system disorder—Epirubicin—prostate cancer	6.39e-05	0.000266	CcSEcCtD
Rotigotine—Dizziness—Docetaxel—prostate cancer	6.38e-05	0.000266	CcSEcCtD
Rotigotine—Hypertension—Doxorubicin—prostate cancer	6.37e-05	0.000266	CcSEcCtD
Rotigotine—Skin disorder—Epirubicin—prostate cancer	6.32e-05	0.000264	CcSEcCtD
Rotigotine—Hyperhidrosis—Epirubicin—prostate cancer	6.29e-05	0.000263	CcSEcCtD
Rotigotine—Arthralgia—Doxorubicin—prostate cancer	6.29e-05	0.000262	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	6.24e-05	0.00026	CcSEcCtD
Rotigotine—Discomfort—Doxorubicin—prostate cancer	6.21e-05	0.000259	CcSEcCtD
Rotigotine—Anorexia—Epirubicin—prostate cancer	6.21e-05	0.000259	CcSEcCtD
Rotigotine—Dizziness—Capecitabine—prostate cancer	6.18e-05	0.000258	CcSEcCtD
Rotigotine—Dry mouth—Doxorubicin—prostate cancer	6.15e-05	0.000256	CcSEcCtD
Rotigotine—Vomiting—Docetaxel—prostate cancer	6.14e-05	0.000256	CcSEcCtD
Rotigotine—Hypersensitivity—Prednisone—prostate cancer	6.13e-05	0.000256	CcSEcCtD
Rotigotine—Rash—Docetaxel—prostate cancer	6.09e-05	0.000254	CcSEcCtD
Rotigotine—Hypotension—Epirubicin—prostate cancer	6.08e-05	0.000254	CcSEcCtD
Rotigotine—Dermatitis—Docetaxel—prostate cancer	6.08e-05	0.000254	CcSEcCtD
Rotigotine—Confusional state—Doxorubicin—prostate cancer	6.08e-05	0.000253	CcSEcCtD
Rotigotine—Headache—Docetaxel—prostate cancer	6.05e-05	0.000252	CcSEcCtD
Rotigotine—Infection—Doxorubicin—prostate cancer	5.99e-05	0.00025	CcSEcCtD
Rotigotine—Asthenia—Prednisone—prostate cancer	5.97e-05	0.000249	CcSEcCtD
Rotigotine—Vomiting—Capecitabine—prostate cancer	5.94e-05	0.000248	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Epirubicin—prostate cancer	5.93e-05	0.000247	CcSEcCtD
Rotigotine—Shock—Doxorubicin—prostate cancer	5.93e-05	0.000247	CcSEcCtD
Rotigotine—Nervous system disorder—Doxorubicin—prostate cancer	5.91e-05	0.000246	CcSEcCtD
Rotigotine—Rash—Capecitabine—prostate cancer	5.89e-05	0.000246	CcSEcCtD
Rotigotine—Pruritus—Prednisone—prostate cancer	5.89e-05	0.000246	CcSEcCtD
Rotigotine—Insomnia—Epirubicin—prostate cancer	5.89e-05	0.000246	CcSEcCtD
Rotigotine—Dermatitis—Capecitabine—prostate cancer	5.89e-05	0.000246	CcSEcCtD
Rotigotine—Headache—Capecitabine—prostate cancer	5.86e-05	0.000244	CcSEcCtD
Rotigotine—Skin disorder—Doxorubicin—prostate cancer	5.85e-05	0.000244	CcSEcCtD
Rotigotine—Paraesthesia—Epirubicin—prostate cancer	5.85e-05	0.000244	CcSEcCtD
Rotigotine—Hyperhidrosis—Doxorubicin—prostate cancer	5.82e-05	0.000243	CcSEcCtD
Rotigotine—Somnolence—Epirubicin—prostate cancer	5.79e-05	0.000241	CcSEcCtD
Rotigotine—Anorexia—Doxorubicin—prostate cancer	5.74e-05	0.00024	CcSEcCtD
Rotigotine—Nausea—Docetaxel—prostate cancer	5.73e-05	0.000239	CcSEcCtD
Rotigotine—Dyspepsia—Epirubicin—prostate cancer	5.73e-05	0.000239	CcSEcCtD
Rotigotine—Diarrhoea—Prednisone—prostate cancer	5.7e-05	0.000238	CcSEcCtD
Rotigotine—Decreased appetite—Epirubicin—prostate cancer	5.66e-05	0.000236	CcSEcCtD
Rotigotine—Hypotension—Doxorubicin—prostate cancer	5.63e-05	0.000235	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Epirubicin—prostate cancer	5.62e-05	0.000235	CcSEcCtD
Rotigotine—Fatigue—Epirubicin—prostate cancer	5.61e-05	0.000234	CcSEcCtD
Rotigotine—Pain—Epirubicin—prostate cancer	5.57e-05	0.000232	CcSEcCtD
Rotigotine—Constipation—Epirubicin—prostate cancer	5.57e-05	0.000232	CcSEcCtD
Rotigotine—Nausea—Capecitabine—prostate cancer	5.55e-05	0.000232	CcSEcCtD
Rotigotine—Dizziness—Prednisone—prostate cancer	5.51e-05	0.00023	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Doxorubicin—prostate cancer	5.49e-05	0.000229	CcSEcCtD
Rotigotine—Insomnia—Doxorubicin—prostate cancer	5.45e-05	0.000227	CcSEcCtD
Rotigotine—Paraesthesia—Doxorubicin—prostate cancer	5.41e-05	0.000226	CcSEcCtD
Rotigotine—Feeling abnormal—Epirubicin—prostate cancer	5.37e-05	0.000224	CcSEcCtD
Rotigotine—Somnolence—Doxorubicin—prostate cancer	5.36e-05	0.000223	CcSEcCtD
Rotigotine—Dyspepsia—Doxorubicin—prostate cancer	5.3e-05	0.000221	CcSEcCtD
Rotigotine—Vomiting—Prednisone—prostate cancer	5.29e-05	0.000221	CcSEcCtD
Rotigotine—Rash—Prednisone—prostate cancer	5.25e-05	0.000219	CcSEcCtD
Rotigotine—Dermatitis—Prednisone—prostate cancer	5.24e-05	0.000219	CcSEcCtD
Rotigotine—Decreased appetite—Doxorubicin—prostate cancer	5.24e-05	0.000218	CcSEcCtD
Rotigotine—Headache—Prednisone—prostate cancer	5.22e-05	0.000218	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Doxorubicin—prostate cancer	5.2e-05	0.000217	CcSEcCtD
Rotigotine—Fatigue—Doxorubicin—prostate cancer	5.19e-05	0.000217	CcSEcCtD
Rotigotine—Urticaria—Epirubicin—prostate cancer	5.17e-05	0.000216	CcSEcCtD
Rotigotine—Constipation—Doxorubicin—prostate cancer	5.15e-05	0.000215	CcSEcCtD
Rotigotine—Pain—Doxorubicin—prostate cancer	5.15e-05	0.000215	CcSEcCtD
Rotigotine—Feeling abnormal—Doxorubicin—prostate cancer	4.96e-05	0.000207	CcSEcCtD
Rotigotine—Nausea—Prednisone—prostate cancer	4.95e-05	0.000206	CcSEcCtD
Rotigotine—Hypersensitivity—Epirubicin—prostate cancer	4.8e-05	0.0002	CcSEcCtD
Rotigotine—Urticaria—Doxorubicin—prostate cancer	4.79e-05	0.0002	CcSEcCtD
Rotigotine—Asthenia—Epirubicin—prostate cancer	4.67e-05	0.000195	CcSEcCtD
Rotigotine—Pruritus—Epirubicin—prostate cancer	4.61e-05	0.000192	CcSEcCtD
Rotigotine—Diarrhoea—Epirubicin—prostate cancer	4.46e-05	0.000186	CcSEcCtD
Rotigotine—Hypersensitivity—Doxorubicin—prostate cancer	4.44e-05	0.000185	CcSEcCtD
Rotigotine—Asthenia—Doxorubicin—prostate cancer	4.32e-05	0.00018	CcSEcCtD
Rotigotine—Dizziness—Epirubicin—prostate cancer	4.31e-05	0.00018	CcSEcCtD
Rotigotine—Pruritus—Doxorubicin—prostate cancer	4.26e-05	0.000178	CcSEcCtD
Rotigotine—Vomiting—Epirubicin—prostate cancer	4.14e-05	0.000173	CcSEcCtD
Rotigotine—Diarrhoea—Doxorubicin—prostate cancer	4.12e-05	0.000172	CcSEcCtD
Rotigotine—Rash—Epirubicin—prostate cancer	4.11e-05	0.000171	CcSEcCtD
Rotigotine—Dermatitis—Epirubicin—prostate cancer	4.1e-05	0.000171	CcSEcCtD
Rotigotine—Headache—Epirubicin—prostate cancer	4.08e-05	0.00017	CcSEcCtD
Rotigotine—Dizziness—Doxorubicin—prostate cancer	3.98e-05	0.000166	CcSEcCtD
Rotigotine—Nausea—Epirubicin—prostate cancer	3.87e-05	0.000161	CcSEcCtD
Rotigotine—Vomiting—Doxorubicin—prostate cancer	3.83e-05	0.00016	CcSEcCtD
Rotigotine—Rash—Doxorubicin—prostate cancer	3.8e-05	0.000158	CcSEcCtD
Rotigotine—Dermatitis—Doxorubicin—prostate cancer	3.8e-05	0.000158	CcSEcCtD
Rotigotine—Headache—Doxorubicin—prostate cancer	3.77e-05	0.000157	CcSEcCtD
Rotigotine—Nausea—Doxorubicin—prostate cancer	3.58e-05	0.000149	CcSEcCtD
Rotigotine—CYP3A4—Metabolism—ACHE—prostate cancer	4.53e-06	3.65e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—GGT1—prostate cancer	4.53e-06	3.65e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CXCL8—prostate cancer	4.52e-06	3.64e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—GSK3B—prostate cancer	4.51e-06	3.63e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—FGF2—prostate cancer	4.51e-06	3.63e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CYP2A6—prostate cancer	4.48e-06	3.61e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CDKN1B—prostate cancer	4.48e-06	3.6e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—JAK2—prostate cancer	4.47e-06	3.6e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—TYMS—prostate cancer	4.47e-06	3.59e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—AKT1—prostate cancer	4.47e-06	3.59e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—NCOA1—prostate cancer	4.46e-06	3.59e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—INS—prostate cancer	4.45e-06	3.58e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—NOS3—prostate cancer	4.44e-06	3.58e-05	CbGpPWpGaD
Rotigotine—DRD1—GPCR downstream signaling—AKT1—prostate cancer	4.43e-06	3.56e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CDKN1B—prostate cancer	4.42e-06	3.55e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—GSTM1—prostate cancer	4.42e-06	3.55e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—CYP19A1—prostate cancer	4.4e-06	3.54e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CASP3—prostate cancer	4.39e-06	3.53e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—PIK3CA—prostate cancer	4.39e-06	3.53e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—IL2—prostate cancer	4.38e-06	3.53e-05	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—PIK3CA—prostate cancer	4.38e-06	3.52e-05	CbGpPWpGaD
Rotigotine—DRD3—GPCR downstream signaling—AKT1—prostate cancer	4.37e-06	3.52e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—MDM2—prostate cancer	4.37e-06	3.51e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—EP300—prostate cancer	4.37e-06	3.51e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—IL6—prostate cancer	4.36e-06	3.51e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—AKR1C3—prostate cancer	4.36e-06	3.51e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CREBBP—prostate cancer	4.36e-06	3.51e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PRKACB—prostate cancer	4.34e-06	3.49e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—LPL—prostate cancer	4.33e-06	3.49e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CASP3—prostate cancer	4.33e-06	3.48e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—IL2—prostate cancer	4.32e-06	3.48e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—JAK2—prostate cancer	4.32e-06	3.48e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—ERBB2—prostate cancer	4.31e-06	3.46e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—IGF1—prostate cancer	4.3e-06	3.46e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—IL6—prostate cancer	4.3e-06	3.46e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CYP17A1—prostate cancer	4.29e-06	3.45e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—EGFR—prostate cancer	4.28e-06	3.45e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CCND1—prostate cancer	4.27e-06	3.44e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—PIK3CB—prostate cancer	4.25e-06	3.42e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—SRC—prostate cancer	4.25e-06	3.42e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—RXRA—prostate cancer	4.25e-06	3.42e-05	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—TP53—prostate cancer	4.23e-06	3.41e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—PIK3CA—prostate cancer	4.23e-06	3.41e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CTNNB1—prostate cancer	4.23e-06	3.4e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—MDM2—prostate cancer	4.22e-06	3.39e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CCND1—prostate cancer	4.21e-06	3.39e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—CYP1A1—prostate cancer	4.19e-06	3.37e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CTNNB1—prostate cancer	4.17e-06	3.36e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—MAP2K1—prostate cancer	4.16e-06	3.35e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—ERBB2—prostate cancer	4.16e-06	3.34e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—ERCC2—prostate cancer	4.15e-06	3.34e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—MMP9—prostate cancer	4.15e-06	3.34e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—VEGFA—prostate cancer	4.14e-06	3.33e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—PIK3CD—prostate cancer	4.13e-06	3.32e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CDKN1A—prostate cancer	4.13e-06	3.32e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	4.13e-06	3.32e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—PTEN—prostate cancer	4.12e-06	3.32e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—PIK3CB—prostate cancer	4.1e-06	3.3e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—STAT3—prostate cancer	4.1e-06	3.3e-05	CbGpPWpGaD
Rotigotine—DRD2—GPCR downstream signaling—PIK3CA—prostate cancer	4.09e-06	3.29e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—MMP9—prostate cancer	4.09e-06	3.29e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—COMT—prostate cancer	4.09e-06	3.29e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—NCOA2—prostate cancer	4.09e-06	3.29e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—SERPINE1—prostate cancer	4.09e-06	3.29e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CXCL8—prostate cancer	4.08e-06	3.29e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CDKN1A—prostate cancer	4.08e-06	3.28e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—GSTP1—prostate cancer	4.07e-06	3.28e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—PTEN—prostate cancer	4.07e-06	3.27e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—KRAS—prostate cancer	4.05e-06	3.26e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—AKT1—prostate cancer	4.02e-06	3.24e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—ITPR1—prostate cancer	4.01e-06	3.22e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CDKN1B—prostate cancer	3.99e-06	3.21e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—AKT1—prostate cancer	3.97e-06	3.19e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—FGF2—prostate cancer	3.96e-06	3.18e-05	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR downstream signaling—AKT1—prostate cancer	3.95e-06	3.17e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CXCL8—prostate cancer	3.94e-06	3.17e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	3.94e-06	3.17e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—EP300—prostate cancer	3.93e-06	3.16e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CASP3—prostate cancer	3.91e-06	3.14e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—MTHFR—prostate cancer	3.9e-06	3.14e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—IL2—prostate cancer	3.9e-06	3.14e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—NOS3—prostate cancer	3.9e-06	3.14e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—SLC5A5—prostate cancer	3.9e-06	3.14e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—IL6—prostate cancer	3.88e-06	3.12e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—EP300—prostate cancer	3.88e-06	3.12e-05	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—IL6—prostate cancer	3.88e-06	3.12e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CDKN1B—prostate cancer	3.85e-06	3.1e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PPARA—prostate cancer	3.83e-06	3.08e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—SRC—prostate cancer	3.82e-06	3.08e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CYP2E1—prostate cancer	3.81e-06	3.07e-05	CbGpPWpGaD
Rotigotine—HTR1A—GPCR downstream signaling—AKT1—prostate cancer	3.81e-06	3.06e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—MYC—prostate cancer	3.81e-06	3.06e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CCND1—prostate cancer	3.8e-06	3.06e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—TGFB1—prostate cancer	3.8e-06	3.05e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—JAK2—prostate cancer	3.79e-06	3.05e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—TYMS—prostate cancer	3.78e-06	3.05e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CASP3—prostate cancer	3.77e-06	3.04e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—SRC—prostate cancer	3.77e-06	3.03e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CTNNB1—prostate cancer	3.77e-06	3.03e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—IL2—prostate cancer	3.77e-06	3.03e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—NQO1—prostate cancer	3.77e-06	3.03e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—IL6—prostate cancer	3.75e-06	3.02e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—GSTM1—prostate cancer	3.74e-06	3.01e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—VEGFA—prostate cancer	3.72e-06	3e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—EGFR—prostate cancer	3.72e-06	2.99e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—PIK3CA—prostate cancer	3.72e-06	2.99e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—TH—prostate cancer	3.71e-06	2.99e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—MDM2—prostate cancer	3.7e-06	2.98e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—MMP9—prostate cancer	3.69e-06	2.97e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—STAT3—prostate cancer	3.69e-06	2.97e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CDKN1A—prostate cancer	3.68e-06	2.96e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—VEGFA—prostate cancer	3.67e-06	2.96e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CCND1—prostate cancer	3.67e-06	2.95e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—LPL—prostate cancer	3.67e-06	2.95e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—PTEN—prostate cancer	3.67e-06	2.95e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—ERBB2—prostate cancer	3.65e-06	2.94e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—STAT3—prostate cancer	3.64e-06	2.93e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CTNNB1—prostate cancer	3.64e-06	2.93e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CYP1B1—prostate cancer	3.61e-06	2.91e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—PIK3CB—prostate cancer	3.6e-06	2.9e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—CAV1—prostate cancer	3.6e-06	2.9e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—AKT1—prostate cancer	3.58e-06	2.88e-05	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—AKT1—prostate cancer	3.58e-06	2.88e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—MMP9—prostate cancer	3.57e-06	2.87e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CDKN1A—prostate cancer	3.55e-06	2.86e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—CYP1A1—prostate cancer	3.55e-06	2.85e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—PTEN—prostate cancer	3.54e-06	2.85e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—ERCC2—prostate cancer	3.52e-06	2.83e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—KRAS—prostate cancer	3.52e-06	2.83e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—EP300—prostate cancer	3.5e-06	2.82e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—GGT1—prostate cancer	3.5e-06	2.81e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CXCL8—prostate cancer	3.46e-06	2.78e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—AKT1—prostate cancer	3.46e-06	2.78e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—NCOA1—prostate cancer	3.45e-06	2.77e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—MYC—prostate cancer	3.43e-06	2.76e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—TGFB1—prostate cancer	3.42e-06	2.75e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—SRC—prostate cancer	3.41e-06	2.74e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CYP19A1—prostate cancer	3.4e-06	2.73e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—EP300—prostate cancer	3.38e-06	2.72e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—MYC—prostate cancer	3.38e-06	2.72e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CDKN1B—prostate cancer	3.38e-06	2.72e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—TGFB1—prostate cancer	3.37e-06	2.71e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—EGFR—prostate cancer	3.35e-06	2.7e-05	CbGpPWpGaD
Rotigotine—DRD2—GPCR downstream signaling—AKT1—prostate cancer	3.34e-06	2.69e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—VEGFA—prostate cancer	3.32e-06	2.67e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CASP3—prostate cancer	3.31e-06	2.67e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—IL2—prostate cancer	3.31e-06	2.66e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—MTHFR—prostate cancer	3.31e-06	2.66e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—EGFR—prostate cancer	3.31e-06	2.66e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—IL6—prostate cancer	3.29e-06	2.65e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—SRC—prostate cancer	3.29e-06	2.64e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—STAT3—prostate cancer	3.28e-06	2.64e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PIK3CG—prostate cancer	3.28e-06	2.64e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—RXRA—prostate cancer	3.28e-06	2.64e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PPARA—prostate cancer	3.24e-06	2.61e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—PIK3CA—prostate cancer	3.23e-06	2.6e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CCND1—prostate cancer	3.22e-06	2.59e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—VEGFA—prostate cancer	3.2e-06	2.58e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CTNNB1—prostate cancer	3.19e-06	2.57e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—STAT3—prostate cancer	3.17e-06	2.55e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—KRAS—prostate cancer	3.17e-06	2.55e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—COMT—prostate cancer	3.16e-06	2.54e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—GSTP1—prostate cancer	3.14e-06	2.53e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—MMP9—prostate cancer	3.13e-06	2.52e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—TP53—prostate cancer	3.13e-06	2.51e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—KRAS—prostate cancer	3.12e-06	2.51e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CDKN1A—prostate cancer	3.12e-06	2.51e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—PTEN—prostate cancer	3.11e-06	2.5e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—INS—prostate cancer	3.1e-06	2.5e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—ITPR1—prostate cancer	3.09e-06	2.49e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—MYC—prostate cancer	3.05e-06	2.46e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—CAV1—prostate cancer	3.05e-06	2.45e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—TGFB1—prostate cancer	3.04e-06	2.45e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—CREBBP—prostate cancer	3.04e-06	2.45e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—AKT1—prostate cancer	3.04e-06	2.44e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—EGFR—prostate cancer	2.98e-06	2.4e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—EP300—prostate cancer	2.97e-06	2.39e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—MYC—prostate cancer	2.95e-06	2.37e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—TGFB1—prostate cancer	2.94e-06	2.36e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—TYMS—prostate cancer	2.92e-06	2.35e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.91e-06	2.34e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—PIK3CA—prostate cancer	2.91e-06	2.34e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—GSTM1—prostate cancer	2.89e-06	2.32e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—SRC—prostate cancer	2.89e-06	2.32e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PIK3CD—prostate cancer	2.88e-06	2.32e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—EGFR—prostate cancer	2.88e-06	2.32e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—PIK3CA—prostate cancer	2.87e-06	2.31e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—IL6—prostate cancer	2.86e-06	2.3e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—LPL—prostate cancer	2.83e-06	2.28e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—KRAS—prostate cancer	2.82e-06	2.27e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—TP53—prostate cancer	2.81e-06	2.26e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—VEGFA—prostate cancer	2.81e-06	2.26e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—STAT3—prostate cancer	2.78e-06	2.24e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PIK3CG—prostate cancer	2.78e-06	2.24e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—TP53—prostate cancer	2.78e-06	2.23e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CYP1A1—prostate cancer	2.74e-06	2.2e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—NOS3—prostate cancer	2.72e-06	2.19e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—KRAS—prostate cancer	2.72e-06	2.19e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—ERCC2—prostate cancer	2.71e-06	2.18e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—AKT1—prostate cancer	2.64e-06	2.12e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—INS—prostate cancer	2.63e-06	2.12e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—PIK3CA—prostate cancer	2.59e-06	2.08e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—MYC—prostate cancer	2.59e-06	2.08e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—TGFB1—prostate cancer	2.58e-06	2.08e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—CREBBP—prostate cancer	2.58e-06	2.07e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—IL6—prostate cancer	2.58e-06	2.07e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—MTHFR—prostate cancer	2.55e-06	2.05e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—IL6—prostate cancer	2.54e-06	2.04e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—EGFR—prostate cancer	2.53e-06	2.04e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PIK3CB—prostate cancer	2.51e-06	2.02e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—TP53—prostate cancer	2.51e-06	2.02e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PPARA—prostate cancer	2.5e-06	2.01e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—PIK3CA—prostate cancer	2.5e-06	2.01e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PTGS2—prostate cancer	2.49e-06	2e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PIK3CD—prostate cancer	2.44e-06	1.96e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—TP53—prostate cancer	2.42e-06	1.95e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—KRAS—prostate cancer	2.39e-06	1.92e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—AKT1—prostate cancer	2.38e-06	1.91e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CAV1—prostate cancer	2.35e-06	1.89e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—AKT1—prostate cancer	2.34e-06	1.89e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—NOS3—prostate cancer	2.31e-06	1.86e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—IL6—prostate cancer	2.29e-06	1.85e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—IL6—prostate cancer	2.21e-06	1.78e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—PIK3CA—prostate cancer	2.2e-06	1.77e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PTEN—prostate cancer	2.17e-06	1.75e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PIK3CG—prostate cancer	2.14e-06	1.72e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PIK3CB—prostate cancer	2.13e-06	1.71e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—TP53—prostate cancer	2.12e-06	1.71e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—AKT1—prostate cancer	2.12e-06	1.7e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PTGS2—prostate cancer	2.11e-06	1.7e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—EP300—prostate cancer	2.07e-06	1.67e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—AKT1—prostate cancer	2.04e-06	1.64e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—INS—prostate cancer	2.03e-06	1.63e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CREBBP—prostate cancer	1.99e-06	1.6e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—IL6—prostate cancer	1.94e-06	1.56e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.88e-06	1.52e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PTEN—prostate cancer	1.84e-06	1.48e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—AKT1—prostate cancer	1.79e-06	1.44e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—NOS3—prostate cancer	1.78e-06	1.43e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—EP300—prostate cancer	1.75e-06	1.41e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PIK3CB—prostate cancer	1.64e-06	1.32e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PTGS2—prostate cancer	1.63e-06	1.31e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PIK3CA—prostate cancer	1.53e-06	1.23e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PTEN—prostate cancer	1.42e-06	1.14e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—EP300—prostate cancer	1.35e-06	1.09e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PIK3CA—prostate cancer	1.3e-06	1.04e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—AKT1—prostate cancer	1.25e-06	1.01e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—AKT1—prostate cancer	1.06e-06	8.53e-06	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PIK3CA—prostate cancer	1e-06	8.06e-06	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—AKT1—prostate cancer	8.18e-07	6.58e-06	CbGpPWpGaD
